Activity of Apramycin Against Carbapenem-Resistant and Hypervirulent Isolates

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2020 Apr 2

PMID 32231657

Citations 24

Authors

Mingju Hao

Xiaohong Shi

Jingnan Lv

Siqiang Niu

Shiqing Cheng

Hong Du

Fangyou Yu

Yi-Wei Tang

Barry N Kreiswirth

Haifang Zhang

Liang Chen

Affiliations

Soon will be listed here.

Abstract

Objective: The emergence of carbapenem-resistant and hypervirulent (CR-hvKp) strains poses a significant public threat, and effective antimicrobial therapy is urgently needed. Recent studies indicated that apramycin is a potent antibiotic with good activity against a range of multi-drug resistant pathogens. In this study, we evaluated the activity of apramycin against clinical CR-hvKp along with carbapenem-resistant non-hvKp (CR-non-hvKp) isolates.

Methods: Broth microdilution method was used to evaluate the activities of apramycin, gentamicin, amikacin, imipenem, meropenem, doripenem, ertapenem and other comparator "last-resort" antimicrobial agents, including ceftazidime-avibactam, colistin and tigecycline, against eighty-four CR-hvKp and forty CR-non-hvKp isolates collected from three Chinese hospitals. Multilocus Sequence typing (MLST), molecular capsule typing ( sequencing) and antimicrobial resistance genes were examined by PCR and Sanger sequencing. Pulsed-field gel electrophoresis and next generation sequencing were conducted on selected isolates.

Results: Among the 84 CR-hvKp isolates, 97.6, 100, 97.6, and 100% were resistant to imipenem, meropenem, doripenem and ertapenem, respectively. Apramycin demonstrated an MIC/MIC of 4/8 μg/mL against the CR-hvKp isolates. In contrast, the MIC/MIC for amikacin and gentamicin were >64/>64 μg/mL. All CR-hvKp isolates were susceptible to ceftazidime-avibactam, colistin and tigecycline with the MIC/MIC values of 0.5/1, 0.25/0.5, 1/1, respectively. For CR-non-hvKp, The MIC values for apramycin, gentamicin and amikacin were 2/8, >64/>64, and >64/>64 μg/mL, respectively. There were no statistical significance in the resistance rates of antimicrobial agents between CR-hvKp and CR-non-hvKp groups ( > 0.05). Genetic analysis revealed that all CR-hvKp isolates harbored , and 94% ( = 79) belong to the ST11 high-risk clone. 93.6% (44/47) of amikacin or gentamicin resistant strains carried 16S rRNA methyltransferases gene .

Conclusion: Apramycin demonstrated potent activity against CR-hvKp isolates, including those were resistant to amikacin or gentamicin. Further studies are needed to evaluate the applicability of apramycin to be used as a therapeutic antibiotic against CR-hvKp infections.

Citing Articles

Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis.

Wang Y, Sholeh M, Yang L, Shakourzadeh M, Beig M, Azizian K Antimicrob Resist Infect Control. 2025; 14(1):10.

PMID: 39934901 PMC: 11818042. DOI: 10.1186/s13756-025-01518-5.

A Decade-Long Review of the Virulence, Resistance, and Epidemiological Risks of in ICUs.

Chen T, Chuang Y, Lin C Microorganisms. 2025; 12(12.

PMID: 39770751 PMC: 11678397. DOI: 10.3390/microorganisms12122548.

Collateral Sensitivity to β-Lactam Antibiotics in Evolved Apramycin-Resistant MRSA.

Wu J, Wu S, Liu J, Li C, Zheng M, Li F Int J Mol Sci. 2024; 25(22).

PMID: 39596355 PMC: 11594749. DOI: 10.3390/ijms252212292.

Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses.

Melchiorri D, Rocke T, Alm R, Cameron A, Gigante V Lancet Microbe. 2024; 6(3):100992.

PMID: 39454608 PMC: 11876093. DOI: 10.1016/j.lanmic.2024.100992.

Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant .

Lee Y, Ponnampalavanar S, Wong J, Kong Z, Ngoi S, Karunakaran R Front Cell Infect Microbiol. 2024; 14:1464816.

PMID: 39359938 PMC: 11445613. DOI: 10.3389/fcimb.2024.1464816.

References

Yang X, Chan E, Zhang R, Chen S . A conjugative plasmid that augments virulence in Klebsiella pneumoniae. Nat Microbiol. 2019; 4(12):2039-2043. DOI: 10.1038/s41564-019-0566-7. View

Ishikawa M, Garcia-Mateo N, cusak A, Lopez-Hernandez I, Fernandez-Martinez M, Muller M . Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use. Sci Rep. 2019; 9(1):2410. PMC: 6382871. DOI: 10.1038/s41598-019-38634-3. View

Zhang X, Ding L, Fan M . Resistance patterns and detection of aac(3)-IV gene in apramycin-resistant Escherichia coli isolated from farm animals and farm workers in northeastern of China. Res Vet Sci. 2009; 87(3):449-54. DOI: 10.1016/j.rvsc.2009.05.006. View

Johnson A, Malde M, Woodford N, Cunney R, Smyth E . Urinary isolates of apramycin-resistant Escherichia coli and Klebsiella pneumoniae from Dublin. Epidemiol Infect. 1995; 114(1):105-12. PMC: 2271345. DOI: 10.1017/s0950268800051955. View

Sun J, Chen C, Cui C, Zhang Y, Liu X, Cui Z . Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat Microbiol. 2019; 4(9):1457-1464. PMC: 6707864. DOI: 10.1038/s41564-019-0496-4. View

Galani I, Nafplioti K, Adamou P, Karaiskos I, Giamarellou H, Souli M . Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance. BMC Infect Dis. 2019; 19(1):167. PMC: 6377745. DOI: 10.1186/s12879-019-3801-1. View

Fritsche T, Castanheira M, Miller G, Jones R, Armstrong E . Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother. 2008; 52(5):1843-5. PMC: 2346617. DOI: 10.1128/AAC.01477-07. View

Wozniak J, Band V, Conley A, Rishishwar L, Burd E, Satola S . A Nationwide Screen of Carbapenem-Resistant Klebsiella pneumoniae Reveals an Isolate with Enhanced Virulence and Clinically Undetected Colistin Heteroresistance. Antimicrob Agents Chemother. 2019; 63(5). PMC: 6496084. DOI: 10.1128/AAC.00107-19. View

Hunter J, Hart C, Shelley J, Walton J, Bennett M . Human isolates of apramycin-resistant Escherichia coli which contain the genes for the AAC(3)IV enzyme. Epidemiol Infect. 1993; 110(2):253-9. PMC: 2272248. DOI: 10.1017/s0950268800068175. View

10.

Cejas D, Canigia L, Rincon Cruz G, Elena A, Maldonado I, Gutkind G . First isolate of KPC-2-producing Klebsiella pneumonaie sequence type 23 from the Americas. J Clin Microbiol. 2014; 52(9):3483-5. PMC: 4313191. DOI: 10.1128/JCM.00726-14. View

11.

Ramirez M, Tolmasky M . Aminoglycoside modifying enzymes. Drug Resist Updat. 2010; 13(6):151-71. PMC: 2992599. DOI: 10.1016/j.drup.2010.08.003. View

12.

Bengoechea J, Sa Pessoa J . Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev. 2018; 43(2):123-144. PMC: 6435446. DOI: 10.1093/femsre/fuy043. View

13.

He T, Wang R, Liu D, Walsh T, Zhang R, Lv Y . Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat Microbiol. 2019; 4(9):1450-1456. DOI: 10.1038/s41564-019-0445-2. View

14.

Chaslus-Dancla E, Glupcznski Y, Gerbaud G, Lagorce M, Lafont J, Courvalin P . Detection of apramycin resistant Enterobacteriaceae in hospital isolates. FEMS Microbiol Lett. 1989; 52(3):261-5. DOI: 10.1016/0378-1097(89)90208-5. View

15.

Larsen M, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig R . Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012; 50(4):1355-61. PMC: 3318499. DOI: 10.1128/JCM.06094-11. View

16.

Matt T, Ng C, Lang K, Sha S, Akbergenov R, Shcherbakov D . Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci U S A. 2012; 109(27):10984-9. PMC: 3390888. DOI: 10.1073/pnas.1204073109. View

17.

Chen L, Mediavilla J, Endimiani A, Rosenthal M, Zhao Y, Bonomo R . Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants. J Clin Microbiol. 2010; 49(2):579-85. PMC: 3043520. DOI: 10.1128/JCM.01588-10. View

18.

Chaslus-Dancla E, Pohl P, Meurisse M, Marin M, Lafont J . High genetic homology between plasmids of human and animal origins conferring resistance to the aminoglycosides gentamicin and apramycin. Antimicrob Agents Chemother. 1991; 35(3):590-3. PMC: 245058. DOI: 10.1128/AAC.35.3.590. View

19.

Brisse S, Passet V, Haugaard A, Babosan A, Kassis-Chikhani N, Struve C . wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol. 2013; 51(12):4073-8. PMC: 3838100. DOI: 10.1128/JCM.01924-13. View

20.

Threlfall E, Rowe B, Ferguson J, Ward L . Characterization of plasmids conferring resistance to gentamicin and apramycin in strains of Salmonella typhimurium phage type 204c isolated in Britain. J Hyg (Lond). 1986; 97(3):419-26. PMC: 2082898. DOI: 10.1017/s0022172400063609. View